SELLAS Life Sciences Group, Inc.
SLS
$1.41
$0.010.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.30% | 15.77% | 4.55% | -0.43% | 9.59% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.79% | -5.63% | 1.28% | 25.87% | -78.19% |
| Change in Net Operating Assets | -298.68% | -171.53% | -103.09% | -33.84% | -40.70% |
| Cash from Operations | -12.71% | -4.21% | -5.13% | -4.37% | -31.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -20.00% | -22.22% | -22.22% |
| Cash from Investing | -- | 100.00% | -20.00% | -22.22% | -22.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 109.26% | 152.26% | 53.11% | -29.86% | -7.08% |
| Repurchase of Common Stock | -6.67% | -6.90% | -6.90% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 109.54% | 152.47% | 53.18% | -30.00% | -7.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 177.81% | 198.18% | 64.64% | -156.86% | -245.04% |